152 related articles for article (PubMed ID: 6162619)
1. Differential diagnosis of pleural effusions: clinical usefulness of cell marker quantitation.
Vladutiu AO; Brason FW; Adler RH
Chest; 1981 Mar; 79(3):297-301. PubMed ID: 6162619
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of biochemical analysis of pleural effusions. Carcinoembryonic antigen and beta 2 microglobulin.
Vladutiu AO; Adler RH; Brason FW
Am J Clin Pathol; 1979 Feb; 71(2):210-4. PubMed ID: 85412
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
Martinez-Vea A; Gatell JM; Segura F; Heiman C; Elena M; Ballesta AM; Mundo MR
Cancer; 1982 Nov; 50(9):1783-8. PubMed ID: 6180821
[TBL] [Abstract][Full Text] [Related]
5. [Clinical usefulness of tumor markers in the diagnosis of pleural effusions. Carcinoembryonic antigen, alpha-fetoprotein and orosomucoid].
Romero Candeira S; Hernández Blasco L; Senent Español C; García Raja A; Zaragoza Zaragoza C; Serralta Buades J; Martín Serrano C
Med Clin (Barc); 1986 Mar; 86(11):439-43. PubMed ID: 2423819
[No Abstract] [Full Text] [Related]
6. Tumor-associated trypsin inhibitor (TATI) in pleural effusions.
Rapellino M; Pecchio F; Baldi S; Adamo MR; Macri M; Ricardi G
Scand J Clin Lab Invest Suppl; 1991; 207():47-9. PubMed ID: 1780690
[TBL] [Abstract][Full Text] [Related]
7. CA-15.3 assay in effusions: comparison with carcinoembryonic antigen and CA-125 assay and cytologic diagnosis.
Pinto MM
Acta Cytol; 1996; 40(3):437-42. PubMed ID: 8669175
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers in pleural effusion diagnosis.
Tamura S; Nishigaki T; Moriwaki Y; Fujioka H; Nakano T; Fujii J; Yamamoto T; Nabeshima K; Hada T; Higashino K
Cancer; 1988 Jan; 61(2):298-302. PubMed ID: 3275487
[TBL] [Abstract][Full Text] [Related]
9. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
10. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
11. New approaches in the diagnostic procedure of malignant pleural effusions.
Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
[TBL] [Abstract][Full Text] [Related]
13. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F
Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
[TBL] [Abstract][Full Text] [Related]
14. [Differential diagnosis of pleural effusions].
Ogino M; Koike K; Satoh K; Arai K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1770-4. PubMed ID: 6476843
[TBL] [Abstract][Full Text] [Related]
15. Detection of malignant pleural effusions by tumor marker evaluation.
Pavesi F; Lotzniker M; Cremaschi P; Marbello L; Acquistapace L; Moratti R
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1005-11. PubMed ID: 3409938
[TBL] [Abstract][Full Text] [Related]
16. Orosomucoid, alpha 2-macroglobulin and immunoglobulins in serum and pleural effusions.
Asseo PP; Tracopoulos GD
Am J Clin Pathol; 1981 Oct; 76(4):437-41. PubMed ID: 7293967
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy.
Gandhi AK; Nayar M; Bihari N; Chandra M
Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
